![](/img/cover-not-exists.png)
Safety, efficacy, tolerability, and pharmacokinetics of a new liquid intravenous immunoglobulin (IVIG) in comparison to Sandoglobulin® in patients with primary immunodeficiencies (PID)
Borte, M., Wahn, U., Farber, C., Bernatowska, E., Adams, C., Andresen, I., Bender, K.Volume:
111
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/s0091-6749(03)80824-2
Date:
February, 2003
File:
PDF, 130 KB
english, 2003